LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 12, Issue -, Pages 3353-3361
Publisher
Informa UK Limited
Online
2020-05-12
DOI
10.2147/cmar.s249979
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis
- (2020) Wei Liu et al. Cancer Management and Research
- MALAT1 long non-coding RNA and breast cancer
- (2019) Gayatri Arun et al. RNA Biology
- The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis
- (2019) You Zhou et al. CANCER BIOLOGY & THERAPY
- MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial–mesenchymal transition via hedgehog signaling pathway
- (2019) Qingcui Song et al. EXPERIMENTAL CELL RESEARCH
- Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma
- (2019) Liyun Liu et al. GENE
- MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway
- (2019) Peng Nan et al. CARCINOGENESIS
- MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4
- (2019) Jingwen Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression
- (2019) Na Zhang et al. Molecular Therapy-Nucleic Acids
- LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21
- (2018) Congxin Wei et al. BIOMEDICINE & PHARMACOTHERAPY
- Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143
- (2018) Qing An et al. BIOMEDICINE & PHARMACOTHERAPY
- MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
- (2018) Junkai Chang et al. OncoTargets and Therapy
- LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancer
- (2018) Aleksandra M. Dudek et al. Cancer Medicine
- Upregulation of LINC00963 facilitates melanoma progression through miR-608/NACC1 pathway and predicts poor prognosis
- (2018) Heling Jiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long non-coding RNAs: The novel diagnostic biomarkers for leukemia
- (2017) Shaoyun Chen et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway
- (2017) Teng Hou et al. Oncotarget
- Identification of long non-coding RNAs that stimulate cell survival in bladder cancer
- (2017) Aleksandra M. Dudek et al. Oncotarget
- Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer
- (2017) Mingwei Chen et al. Oncotarget
- Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2
- (2017) Yonghao Zhan et al. Oncotarget
- Post-transcriptional Regulation of Genes Related to Biological Behaviors of Gastric Cancer by Long Noncoding RNAs and MicroRNAs
- (2017) Wenjing Liu et al. Journal of Cancer
- Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
- (2016) Anbang He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now